Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women

被引:24
作者
Larsen, LF
Andersen, HR
Hansen, AB
Andersen, O
机构
[1] ODENSE UNIV,DEPT ENVIRONM MED,INST COMMUNITY HLTH,ODENSE,DENMARK
[2] ODENSE UNIV HOSP,DEPT CLIN CHEM,DK-5000 ODENSE,DENMARK
[3] ROSKILDE UNIV CTR,INST BIOL & CHEM,DK-4000 ROSKILDE,DENMARK
关键词
activated partial thromboplastin time; antithrombin; cholesterol; factor VII; factor II+VII+X; fibrinogen; HDL; LDL; plasminogen activator inhibitor; platelet; tissue plasminogen activator; triglyceride;
D O I
10.3109/00365519609088613
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Variations in erythrocyte glutathione peroxidase activity, serum concentrations of lipids and lipoproteins and in blood coagulation and fibrinolysis during the menstrual cycle were studied in healthy young women. Blood samples were drawn twice a week for 9 weeks. A group of males was used for estimation of the influence on the results of factors which were not related to the menstrual cycle. Variations during the menstrual cycle were demonstrated in several of the factors analysed. The activity of glutathione peroxidase was lowest at ovulation. The clotting activity of factor II+VII+X and the concentration of fibrinogen were lowest during mid-cycle, and the number of platelets increased in the follicular phase (days 5-9). Statistically significant variations in the fibrinolytic factors analysed (tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)) were not observed during the menstrual cycle. The serum concentrations of cholesterol and LDL cholesterol were significantly higher at the start of the menstrual cycle (days 3-8) than later in the cycle (days 19-24). The concentration of HDL cholesterol was lowest in the late luteal phase (days 23-28).
引用
收藏
页码:241 / 249
页数:9
相关论文
共 30 条
[1]  
BASDEVANT A, 1981, DIABETES METAB, V7, P1
[2]  
Beutler, 1984, RED CELL METABOLISM
[3]   THE EFFECT OF PROLONGED ORAL-CONTRACEPTIVE STEROID USE ON ERYTHROCYTE GLUTATHIONE-PEROXIDASE ACTIVITY [J].
CAPEL, ID ;
JENNER, M ;
WILLIAMS, DC ;
DONALDSON, D ;
NATH, A .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1981, 14 (08) :729-732
[4]  
CEDERBLAD G, 1977, HAEMOSTASIS, V6, P294
[5]   OXIDATIVE STATUS AND ORAL-CONTRACEPTIVE - ITS RELEVANCE TO PLATELET ABNORMALITIES AND CARDIOVASCULAR RISK [J].
CIAVATTI, M ;
RENAUD, S .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 10 (05) :325-338
[6]   VARIATIONS IN PLASMA-VOLUME AFFECT TOTAL AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATIONS DURING THE MENSTRUAL-CYCLE [J].
CULLINANE, EM ;
YURGALEVITCH, SM ;
SARITELLI, AL ;
HERBERT, PN ;
THOMPSON, PD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (08) :965-971
[7]   LIPID AND HORMONAL PROFILE OF PANAMANIAN WOMEN DURING THE MENSTRUAL-CYCLE [J].
DELEON, RG ;
AUSTIN, KL ;
RICHARDS, L ;
GUERRERO, F .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 39 (03) :219-226
[8]  
GEVERSLEUVEN JA, 1987, J LAB CLIN MED, V6, P631
[9]  
JERN C, 1991, THROMB HAEMOSTASIS, V66, P614
[10]   ANTI-THROMBIN-III AND PLATELETS DURING THE NORMAL MENSTRUAL-CYCLE AND IN WOMEN RECEIVING ORAL-CONTRACEPTIVES LOW IN ESTROGEN [J].
JESPERSEN, J ;
INGEBERG, S ;
BACH, E .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1983, 15 (03) :153-162